APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Hydrochloride Analgesic

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oxycodone Hydrochloride Analgesic Market Outlook and Growth Opportunities 2026

29 December 2025194 pages

Choose your research edition.

Industry ResearchOxycodone Hydrochloride Analgesic Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Hydrochloride Analgesic Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Oxycodone Hydrochloride Analgesic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Hydrochloride Analgesic Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Hydrochloride Analgesic Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oxycodone Hydrochloride Analgesic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oxycodone Hydrochloride Analgesic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oxycodone Hydrochloride Analgesic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxycodone Hydrochloride Analgesic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oxycodone Hydrochloride Analgesic market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oxycodone Hydrochloride Analgesic market include Teva Pharmaceutical Industries Ltd, Mylan, Wellso Pharmaceutical, Purdue Pharma, NEPHARM, Napp Pharmaceuticals, Mallinckrodt, Epic Pharma, LLC and Amneal Pharmaceuticals, Inc.（Impax）, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Oxycodone Hydrochloride Analgesic market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxycodone Hydrochloride Analgesic and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxycodone Hydrochloride Analgesic revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Oxycodone Hydrochloride Analgesic market.

Oxycodone Hydrochloride Analgesic Segment by Company

Teva Pharmaceutical Industries Ltd

Mylan

Wellso Pharmaceutical

Purdue Pharma

NEPHARM

Napp Pharmaceuticals

Mallinckrodt

Epic Pharma, LLC

Amneal Pharmaceuticals, Inc.（Impax）

Oxycodone Hydrochloride Analgesic Segment by Type

Tablets

Injections

Oxycodone Hydrochloride Analgesic Segment by Application

Hospital

Clinic

Others

Oxycodone Hydrochloride Analgesic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oxycodone Hydrochloride Analgesic status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Oxycodone Hydrochloride Analgesic key companies, revenue, market share, and recent developments.

3. To split the Oxycodone Hydrochloride Analgesic breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Oxycodone Hydrochloride Analgesic market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oxycodone Hydrochloride Analgesic significant trends, drivers, influence factors in global and regions.

6. To analyze Oxycodone Hydrochloride Analgesic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Analgesic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Analgesic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Analgesic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oxycodone Hydrochloride Analgesic industry.

Chapter 3: Detailed analysis of Oxycodone Hydrochloride Analgesic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Oxycodone Hydrochloride Analgesic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Oxycodone Hydrochloride Analgesic in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oxycodone Hydrochloride Analgesic Industry Trends Table 2. Oxycodone Hydrochloride Analgesic Industry Drivers Table 3. Oxycodone Hydrochloride Analgesic Industry Opportunities and Challenges Table 4. Oxycodone Hydrochloride Analgesic Industry Restraints Table 5. Global Oxycodone Hydrochloride Analgesic Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oxycodone Hydrochloride Analgesic Revenue Share by Company (2021-2026) Table 7. Global Oxycodone Hydrochloride Analgesic Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Oxycodone Hydrochloride Analgesic Key Company Manufacturing Base & Headquarters Table 9. Global Oxycodone Hydrochloride Analgesic Company, Product Type & Application Table 10. Global Oxycodone Hydrochloride Analgesic Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Oxycodone Hydrochloride Analgesic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tablets Table 15. Significant Companies of Injections Table 16. Global Oxycodone Hydrochloride Analgesic Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Oxycodone Hydrochloride Analgesic Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Oxycodone Hydrochloride Analgesic Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Type (2021-2026) Table 20. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Others Table 24. Global Oxycodone Hydrochloride Analgesic Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oxycodone Hydrochloride Analgesic Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Oxycodone Hydrochloride Analgesic Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Application (2021-2026) Table 28. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Application (2027-2032) Table 29. Global Oxycodone Hydrochloride Analgesic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Oxycodone Hydrochloride Analgesic Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Region (2021-2026) Table 32. Global Oxycodone Hydrochloride Analgesic Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Region (2027-2032) Table 34. Global Oxycodone Hydrochloride Analgesic Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Oxycodone Hydrochloride Analgesic Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Oxycodone Hydrochloride Analgesic Sales Value Market Share by Country (2021-2026) Table 37. Global Oxycodone Hydrochloride Analgesic Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Oxycodone Hydrochloride Analgesic Sales Value Market Share by Country (2027-2032) Table 39. Teva Pharmaceutical Industries Ltd Company Information Table 40. Teva Pharmaceutical Industries Ltd Business Overview Table 41. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Product Portfolio Table 43. Teva Pharmaceutical Industries Ltd Recent Development Table 44. Mylan Company Information Table 45. Mylan Business Overview Table 46. Mylan Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Mylan Oxycodone Hydrochloride Analgesic Product Portfolio Table 48. Mylan Recent Development Table 49. Wellso Pharmaceutical Company Information Table 50. Wellso Pharmaceutical Business Overview Table 51. Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Product Portfolio Table 53. Wellso Pharmaceutical Recent Development Table 54. Purdue Pharma Company Information Table 55. Purdue Pharma Business Overview Table 56. Purdue Pharma Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Purdue Pharma Oxycodone Hydrochloride Analgesic Product Portfolio Table 58. Purdue Pharma Recent Development Table 59. NEPHARM Company Information Table 60. NEPHARM Business Overview Table 61. NEPHARM Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. NEPHARM Oxycodone Hydrochloride Analgesic Product Portfolio Table 63. NEPHARM Recent Development Table 64. Napp Pharmaceuticals Company Information Table 65. Napp Pharmaceuticals Business Overview Table 66. Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Product Portfolio Table 68. Napp Pharmaceuticals Recent Development Table 69. Mallinckrodt Company Information Table 70. Mallinckrodt Business Overview Table 71. Mallinckrodt Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Mallinckrodt Oxycodone Hydrochloride Analgesic Product Portfolio Table 73. Mallinckrodt Recent Development Table 74. Epic Pharma, LLC Company Information Table 75. Epic Pharma, LLC Business Overview Table 76. Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Product Portfolio Table 78. Epic Pharma, LLC Recent Development Table 79. Amneal Pharmaceuticals, Inc.（Impax） Company Information Table 80. Amneal Pharmaceuticals, Inc.（Impax） Business Overview Table 81. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Product Portfolio Table 83. Amneal Pharmaceuticals, Inc.（Impax） Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Oxycodone Hydrochloride Analgesic Product Image Figure 2. Global Oxycodone Hydrochloride Analgesic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Hydrochloride Analgesic Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxycodone Hydrochloride Analgesic Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tablets Image Figure 8. Injections Image Figure 9. Global Oxycodone Hydrochloride Analgesic Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Oxycodone Hydrochloride Analgesic Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Oxycodone Hydrochloride Analgesic Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Oxycodone Hydrochloride Analgesic Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Application (2021-2032) Figure 18. Global Oxycodone Hydrochloride Analgesic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Oxycodone Hydrochloride Analgesic Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Oxycodone Hydrochloride Analgesic Sales Value (2021-2032) & (US$ Million) Figure 21. North America Oxycodone Hydrochloride Analgesic Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Oxycodone Hydrochloride Analgesic Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Oxycodone Hydrochloride Analgesic Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Oxycodone Hydrochloride Analgesic Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Oxycodone Hydrochloride Analgesic Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Oxycodone Hydrochloride Analgesic Sales Value (2021-2032) & (US$ Million) Figure 27. South America Oxycodone Hydrochloride Analgesic Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Oxycodone Hydrochloride Analgesic Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Oxycodone Hydrochloride Analgesic Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injections
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Mylan
  • Wellso Pharmaceutical
  • Purdue Pharma
  • NEPHARM
  • Napp Pharmaceuticals
  • Mallinckrodt
  • Epic Pharma, LLC
  • Amneal Pharmaceuticals, Inc.（Impax）

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oxycodone Hydrochloride Analgesic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oxycodone Hydrochloride Analgesic Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Oxycodone Hydrochloride Analgesic Market Dynamics
  1. 2.1 Oxycodone Hydrochloride Analgesic Industry Trends
  2. 2.2 Oxycodone Hydrochloride Analgesic Industry Drivers
  3. 2.3 Oxycodone Hydrochloride Analgesic Industry Opportunities and Challenges
  4. 2.4 Oxycodone Hydrochloride Analgesic Industry Restraints
3 Oxycodone Hydrochloride Analgesic Market by Company
  1. 3.1 Global Oxycodone Hydrochloride Analgesic Company Revenue Ranking in 2025
  2. 3.2 Global Oxycodone Hydrochloride Analgesic Revenue by Company (2021-2026)
  3. 3.3 Global Oxycodone Hydrochloride Analgesic Company Ranking (2024-2026)
  4. 3.4 Global Oxycodone Hydrochloride Analgesic Company Manufacturing Base and Headquarters
  5. 3.5 Global Oxycodone Hydrochloride Analgesic Company Product Type and Application
  6. 3.6 Global Oxycodone Hydrochloride Analgesic Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Oxycodone Hydrochloride Analgesic Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Oxycodone Hydrochloride Analgesic Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Oxycodone Hydrochloride Analgesic Market by Type
  1. 4.1 Oxycodone Hydrochloride Analgesic Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injections
  4. 4.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Type
  5. 4.2.1 Global Oxycodone Hydrochloride Analgesic Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Type (2021-2032)
  7. 4.2.3 Global Oxycodone Hydrochloride Analgesic Sales Value Share by Type (2021-2032)
5 Oxycodone Hydrochloride Analgesic Market by Application
  1. 5.1 Oxycodone Hydrochloride Analgesic Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Application
  6. 5.2.1 Global Oxycodone Hydrochloride Analgesic Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Application (2021-2032)
  8. 5.2.3 Global Oxycodone Hydrochloride Analgesic Sales Value Share by Application (2021-2032)
6 Oxycodone Hydrochloride Analgesic Regional Value Analysis
  1. 6.1 Global Oxycodone Hydrochloride Analgesic Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Region (2021-2032)
  3. 6.2.1 Global Oxycodone Hydrochloride Analgesic Sales Value by Region: 2021-2026
  4. 6.2.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oxycodone Hydrochloride Analgesic Sales Value (2021-2032)
  7. 6.3.2 North America Oxycodone Hydrochloride Analgesic Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Oxycodone Hydrochloride Analgesic Sales Value (2021-2032)
  10. 6.4.2 Europe Oxycodone Hydrochloride Analgesic Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Oxycodone Hydrochloride Analgesic Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Oxycodone Hydrochloride Analgesic Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Oxycodone Hydrochloride Analgesic Sales Value (2021-2032)
  16. 6.6.2 South America Oxycodone Hydrochloride Analgesic Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Oxycodone Hydrochloride Analgesic Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Oxycodone Hydrochloride Analgesic Sales Value Share by Country, 2025 VS 2032
7 Oxycodone Hydrochloride Analgesic Country-level Value Analysis
  1. 7.1 Global Oxycodone Hydrochloride Analgesic Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Country (2021-2032)
  3. 7.2.1 Global Oxycodone Hydrochloride Analgesic Sales Value by Country (2021-2026)
  4. 7.2.2 Global Oxycodone Hydrochloride Analgesic Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Oxycodone Hydrochloride Analgesic Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Oxycodone Hydrochloride Analgesic Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Oxycodone Hydrochloride Analgesic Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd
  2. 8.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Oxycodone Hydrochloride Analgesic Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Wellso Pharmaceutical
  14. 8.3.1 Wellso Pharmaceutical Company Information
  15. 8.3.2 Wellso Pharmaceutical Business Overview
  16. 8.3.3 Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Product Portfolio
  18. 8.3.5 Wellso Pharmaceutical Recent Developments
  19. 8.4 Purdue Pharma
  20. 8.4.1 Purdue Pharma Company Information
  21. 8.4.2 Purdue Pharma Business Overview
  22. 8.4.3 Purdue Pharma Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Purdue Pharma Oxycodone Hydrochloride Analgesic Product Portfolio
  24. 8.4.5 Purdue Pharma Recent Developments
  25. 8.5 NEPHARM
  26. 8.5.1 NEPHARM Company Information
  27. 8.5.2 NEPHARM Business Overview
  28. 8.5.3 NEPHARM Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NEPHARM Oxycodone Hydrochloride Analgesic Product Portfolio
  30. 8.5.5 NEPHARM Recent Developments
  31. 8.6 Napp Pharmaceuticals
  32. 8.6.1 Napp Pharmaceuticals Company Information
  33. 8.6.2 Napp Pharmaceuticals Business Overview
  34. 8.6.3 Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Product Portfolio
  36. 8.6.5 Napp Pharmaceuticals Recent Developments
  37. 8.7 Mallinckrodt
  38. 8.7.1 Mallinckrodt Company Information
  39. 8.7.2 Mallinckrodt Business Overview
  40. 8.7.3 Mallinckrodt Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mallinckrodt Oxycodone Hydrochloride Analgesic Product Portfolio
  42. 8.7.5 Mallinckrodt Recent Developments
  43. 8.8 Epic Pharma, LLC
  44. 8.8.1 Epic Pharma, LLC Company Information
  45. 8.8.2 Epic Pharma, LLC Business Overview
  46. 8.8.3 Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Product Portfolio
  48. 8.8.5 Epic Pharma, LLC Recent Developments
  49. 8.9 Amneal Pharmaceuticals, Inc.（Impax）
  50. 8.9.1 Amneal Pharmaceuticals, Inc.（Impax） Company Information
  51. 8.9.2 Amneal Pharmaceuticals, Inc.（Impax） Business Overview
  52. 8.9.3 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Product Portfolio
  54. 8.9.5 Amneal Pharmaceuticals, Inc.（Impax） Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst